Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination "Changweishu + meropenem + noradrenaline" appears to be a treatment regimen that combines a traditional Chinese medicine (Changweishu) with two conventional Western medications (meropenem and noradrenaline). **Changweishu** is a traditional Chinese medicine formulation that appears to be used for treating gastrointestinal dysfunction, particularly in patients with sepsis. It works by "purging fu-organs to eliminate heat". According to the search results, Changweishu is available in capsule form and has been studied for its effects on tumor-related diarrhea and constipation. **Meropenem** is a carbapenem antibiotic used to treat a variety of bacterial infections. It works by inhibiting cell wall synthesis in bacteria. While not explicitly mentioned in the search results, meropenem is commonly used in the treatment of sepsis, which aligns with the context in which Changweishu is mentioned. **Noradrenaline** (also known as norepinephrine) is a vasopressor medication used to treat hypotension (low blood pressure), particularly in shock states including septic shock. It works by constricting blood vessels to increase blood pressure. Like meropenem, noradrenaline is not explicitly mentioned in the search results but is commonly used in sepsis management. The combination of these three agents suggests a comprehensive approach to treating sepsis with associated gastrointestinal dysfunction, where: - Changweishu addresses the gastrointestinal symptoms - Meropenem targets the underlying infection - Noradrenaline manages the hemodynamic instability (low blood pressure) often seen in sepsis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Changweishu + meropenem + noradrenaline.